1. Home
  2. QURE vs PWP Comparison

QURE vs PWP Comparison

Compare QURE & PWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$17.61

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Perella Weinberg Partners

PWP

Perella Weinberg Partners

HOLD

Current Price

$21.61

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
QURE
PWP
Founded
1998
2006
Country
Netherlands
United States
Employees
248
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
QURE
PWP
Price
$17.61
$21.61
Analyst Decision
Buy
Hold
Analyst Count
14
3
Target Price
$44.92
$23.50
AVG Volume (30 Days)
1.6M
731.6K
Earning Date
05-08-2026
05-01-2026
Dividend Yield
N/A
1.30%
EPS Growth
29.67
138.52
EPS
N/A
0.47
Revenue
$13,107,000.00
N/A
Revenue This Year
$126.12
$31.87
Revenue Next Year
$200.43
$16.54
P/E Ratio
N/A
$45.89
Revenue Growth
N/A
N/A
52 Week Low
$8.73
$14.99
52 Week High
$71.50
$25.93

Technical Indicators

Market Signals
Indicator
QURE
PWP
Relative Strength Index (RSI) 53.07 74.20
Support Level $13.47 $20.70
Resistance Level $18.37 $23.01
Average True Range (ATR) 1.33 0.86
MACD 0.27 0.46
Stochastic Oscillator 87.86 78.61

Price Performance

Historical Comparison
QURE
PWP

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

About PWP Perella Weinberg Partners

Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.

Share on Social Networks: